A significant advance in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in several kinds of malignancies, https://onelifesocial.com/story7422722/nanobodies-revive-p53-the-promising-approach-for-cancer-treatment